Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$492K Sell
4,166
-97
-2% -$12K 0.02% 234
2025
Q4
$536K Buy
4,263
+836
+24% +$109K 0.02% 210
2025
Q3
$501K Buy
3,427
+450
+15% +$68K 0.02% 193
2025
Q2
$464K Buy
2,977
+679
+30% +$108K 0.02% 201
2025
Q1
$378K Buy
2,298
+149
+7% +$24.8K 0.02% 194
2024
Q4
$350K Buy
2,149
+250
+13% +$44.7K 0.02% 194
2024
Q3
$371K Buy
1,899
+500
+36% +$92.1K 0.02% 186
2024
Q2
$243K Buy
+1,399
New +$233K 0.02% 204
2022
Q1
Sell
-956
Closed -$233K 222
2021
Q4
$233K Buy
+956
New +$209K 0.02% 180

Other funds holding ZTS

GM Advisory Group's ZTS Position: Q1 2026 in Review

GM Advisory Group reduced its Zoetis (ZTS) stake by 2.3% in Q1 2026, selling an estimated $12K and leaving 4,166 shares worth $492K. The position accounts for 0.02% of the portfolio, ranked #234.

GM Advisory Group first reported a position in ZTS in Q4 2021 and has held it in 9 quarters since. The position peaked at $536K in Q4 2025. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • GM Advisory Group held 4,166 shares of Zoetis worth $492K as of Q1 2026.
  • GM Advisory Group sold 97 Zoetis shares in Q1 2026, an estimated $12K.
  • Zoetis made up 0.02% of GM Advisory Group's portfolio in Q1 2026, its #234 holding.
  • GM Advisory Group first reported a position in Zoetis in Q4 2021 and has held it in 9 quarters since.
  • GM Advisory Group's Zoetis position peaked at $536K in Q4 2025.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.